Wed 26 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| MENINGOCOCCAL GROUP A, C, W135, Y | MENCEVAX ACWY 50MCG\0.5ML VIAL | 100 | 64.4 | Details | |
| LABETALOL HYDROCHLORIDE | TRANDATE TAB 200 MG. | 200 | 63.6 | Details | |
| TETRACOSACTIDE | SYNACTHEN DEPOT | 1 | 1698 | Details | |
| LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOZIN 5 mg film-coated tablet | 5 | 15.95 | Details | |
| RISPERIDONE | RIDON 1 MG/ML ORAL SOLUTION | 1 | 170.75 | Details | |
| CANDESARTAN CILEXETIL | CANDEPRESS 8 mg tablet | 8 | 44.75 | Details | |
| CANDESARTAN CILEXETIL | CANDEPRESS 16 mg tablet | 16 | 54.6 | Details | |
| CANDESARTAN CILEXETIL | CANDEPRESS 32 mg tablet | 32 | 77.1 | Details | |
| DARUNAVIR | PREZISTA 400 mg film-coated tablet | 400 | 1157.75 | Details | |
| DARUNAVIR | PREZISTA 600 mg film-coated tablet | 600 | 1855.05 | Details | |
| AXITINIB | INLYTA 1 mg film-coated tablet | 1 | 3095.15 | Details | |
| Pasireotide pamoate | SIGNIFOR 0.3 mg solution for injection | 0.3 | 21623.55 | Details | |
| Pasireotide pamoate | SIGNIFOR 0.9 mg solution for injection | 0.9 | 21623.55 | Details | |
| INDAPAMIDE | NORMALIX SR 1.5 mg modified-release tablet | 1.5 | 24.65 | Details | |
| OMBITASVIR, PARITAPREVIR, RITONAVIR | VIEKIRAX film-coated tablet | 12.5, 50, 75 | 81463.75 | Details | |
| DASABUVIR | EXVIERA 250 mg film-coated tablet | 250 | 6439.8 | Details | |
| DACLATASVIR | DAKLINZA 60 mg film-coated tablet | 60 | 41564.8 | Details | |
| PARACETAMOL | PARACETAMOL B.Braun 10 mg/ml solution for infusion | 10 | 14.35 | Details | |
| PANTOPRAZOLE | PANTOL 40 mg enteric-coated tablet | 40 | 69.75 | Details | |
| LOSARTAN POTASSIUM | AZAR 50 mg film-coated tablet | 50 | 45.35 | Details |
5.14% of users said yes from 175 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.